Furthermore, it has been observed in autoimmune diseases such as rheumatoid arthritis, where recent studies show a TNFα inhibitor treatment that reduces insulin resistance, delaying the effects on these rheumatoid arthritis patients [24,25]. The gene discussed is INS; the disease is rheumatoid arthritis.